Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary?
about
Antiviral T-cell therapyMolecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases.Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin.Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.Human Herpesvirus-6 Pneumonitis around the Engraftment of Cord Blood Transplantation following Foscarnet Prophylaxis in a Patient with Acute Leukemia.Optimisation of a quantitative polymerase chain reaction-based strategy for the detection and quantification of human herpesvirus 6 DNA in patients undergoing allogeneic haematopoietic stem cell transplantation.Second allogeneic hematopoietic cell transplantation for graft failure: poor outcomes for neutropenic graft failureExpansion of hematopoietic stem cells for transplantation: current perspectivesUmbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect.Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantationCord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.Adoptive transfer of umbilical cord blood-derived regulatory T cells and early viral reactivation.Molecular diagnosis and management of viral infections in hematopoietic stem cell transplant recipients.HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis.Hepatitis due to human herpesvirus 6B after hematopoietic cell transplantation and a review of the literature.Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know.Chromosomally Integrated Human Herpesvirus 6: Models of Viral Genome Release from the Telomere and Impacts on Human Health.Early human herpes virus type 6 reactivation in umbilical cord blood allogeneic stem cell transplantation.Fatal Myocarditis Associated With HHV-6 Following Immunosuppression in Two ChildrenIdentification of novel CD8+ T cell epitopes in human herpesvirus 6B U11 and U90.Human herpesvirus 6 is associated with status epilepticus and hyponatremia after umbilical cord blood transplantation.Large-scale multiplex polymerase chain reaction assay for diagnosis of viral reactivations after allogeneic hematopoietic stem cell transplantation.Status Epilepticus due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient.Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.Human herpesvirus-6 encephalopathy after hematopoietic stem cell transplantation and class I human leukocyte antigen.Characterizing human herpes virus 6 following hematopoietic stem cell transplantation.Human herpesvirus type 6 DNAemia and infection following allogeneic stem cell transplantation with a focus on long-term outcome.Partial engraftment following plerixafor rescue after failed sibling donor peripheral blood stem cell harvest.Risk factors of human herpesvirus 6 encephalitis/myelitis after allogeneic hematopoietic stem cell transplantation.
P2860
Q27028006-EC6D728C-3412-4A11-8F67-1DD93AEA3073Q33819076-64B65E45-0BC4-4AA0-AB7B-B0D9EC81FBFDQ33897804-292461EE-08BE-40DE-82C4-C7FC759B7483Q34273968-93FC0932-A342-4227-B21B-BD5AFA534651Q35012438-FCDC0AD9-1CD8-47E8-97ED-9AE72A951F02Q35849274-CD85AD79-718C-438A-9B36-C4C1788A57CAQ36083484-04318D89-22B9-4383-A00F-F0B02F7534DDQ36444481-7CF3873C-8B52-4D55-9831-82A08965727EQ36622195-9C16A68D-A890-4514-B3D5-B57D2B337D79Q37006823-058200EC-E60E-4A0C-B768-E1048FB10356Q37276889-7D8C9BE8-2088-487F-ABDF-C70B82DCC9B3Q37408077-45C1C1BA-5C47-4895-871A-AF28772604C5Q38002109-9C391056-FECE-45EA-8F32-6460502C1900Q38045704-02BAB75C-F8CA-4A21-B5AC-9E7099E4D9A8Q38202288-CC954B0D-F39A-41BC-B05B-ACD4A98E1866Q38444117-08E0A2A2-A8A8-40B9-9613-F9C2AF77E311Q39433139-A6C74440-4932-4B96-B0D0-FB42495D67E5Q40849677-8F374D1A-7C2A-4D7B-91A8-DBB7E4717579Q40866127-6D592CD7-ADDD-4165-94F7-B6DDE6987290Q40884483-B3460390-C765-4F01-B7DD-B32FB94FD83CQ41715322-20E7AA79-53B5-4905-B0B6-6BC64491770AQ41758098-743B6670-13A6-4964-8236-C8D6688AD9EBQ41877387-B9EE7DB9-6F18-4F4A-9267-1B41E9824395Q42219821-1D3161E2-909B-45FB-A333-4EEC58495A0DQ42234693-03BA7FB2-4CBC-4ABF-9A08-2577A6101F03Q42244146-DEF89064-E479-4641-BB92-73E1B033C505Q42272500-333A269A-8FDE-4013-97A8-A09BE1B26BC9Q44592988-18CCE71D-7CA3-4FD1-B58B-1D5B0F06A8C8Q47436824-A452CC5A-CF94-4F54-A1F6-C6C09454D1B2
P2860
Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary?
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Human herpesvirus 6 infection ...... outine surveillance necessary?
@ast
Human herpesvirus 6 infection ...... outine surveillance necessary?
@en
type
label
Human herpesvirus 6 infection ...... outine surveillance necessary?
@ast
Human herpesvirus 6 infection ...... outine surveillance necessary?
@en
prefLabel
Human herpesvirus 6 infection ...... outine surveillance necessary?
@ast
Human herpesvirus 6 infection ...... outine surveillance necessary?
@en
P2093
P2860
P1476
Human herpesvirus 6 infection ...... outine surveillance necessary?
@en
P2093
Celalettin Ustun
Daniel J Weisdorf
P2860
P304
P356
10.1016/J.BBMT.2011.04.004
P577
2011-04-20T00:00:00Z